Cemiplimab-Rwlc: Clinical Trials

31 trials of Cemiplimab-Rwlc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 recruiting, 5 active not recruiting, 4 withdrawn, 3 terminated. 22 Phase 2, 9 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 222Recruiting 13, Active not recruiting 3, Withdrawn 3, Terminated 2, Suspended 1
Phase 19Recruiting 4, Active not recruiting 2, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 32Recruiting 1, Suspended 1

Follow Cemiplimab-Rwlc: new trials by email Literature Review of Cemiplimab-Rwlc trials Research Report on Cemiplimab-Rwlc

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
Cemiplimab - Colon and Rectal Cancer
Phase 2RecruitingColumbia University202027-01-012026-11-04
Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma
Actinium Ac 225 Lintuzumab, Biospecimen Collection, Cemiplimab - Recurrent Glioblastoma, IDH-Wildtype, Recurrent Gliosarcoma
Phase 1Not yet recruitingNational Cancer Institute (NCI)302026-12-042026-06-12
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
Cemiplimab-Rwlc - Non-small Cell Lung Cancer Stage III
Phase 2RecruitingGeorgetown University212026-11-012026-10-06
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
Biopsy Procedure, Biospecimen Collection, Carboplatin - Sinonasal Squamous Cell Carcinoma, Stage III Sinonasal Cancer AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)1082026-09-012026-10-05
Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer
Biospecimen Collection, Cemiplimab, Cetuximab Sarotalocan Sodium - Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
Phase 2WithdrawnRoswell Park Cancer Institute2026-08-152026-09-15
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
Biopsy Procedure, Biospecimen Collection, Cemiplimab - Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)862026-08-102026-09-09
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
Anti-CD40 Agonist Monoclonal Antibody CDX-1140, Biopsy Procedure, Biospecimen Collection - Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2RecruitingNational Cancer Institute (NCI)442026-05-272026-10-26
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Biospecimen Collection, Carboplatin, Cemiplimab - Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)1802026-04-242026-10-26
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
Biospecimen Collection, Cabozantinib, Cemiplimab - Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma
Phase 2RecruitingNational Cancer Institute (NCI)482026-02-222026-11-06
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
Biopsy, Biospecimen Collection, Cemiplimab - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 2RecruitingCity of Hope Medical Center112026-01-302026-05-20
Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma
Biopsy Procedure, Biospecimen Collection, Cemiplimab - Metastatic NUT Carcinoma, Unresectable NUT Carcinoma
Phase 2RecruitingNorthwestern University152025-08-152026-08-18
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Biospecimen Collection, Cemiplimab, Computed Tomography - Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2 / Phase 3RecruitingSWOG Cancer Research Network3782025-05-222026-10-09
Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Biospecimen Collection, Cemiplimab, Fianlimab - Lung Non-Small Cell Carcinoma, Stage IB Lung Cancer AJCC v8
Phase 2RecruitingMayo Clinic602025-05-022026-10-29
Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer
Biospecimen Collection, Cemiplimab, Computed Tomography - Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain
Phase 2WithdrawnCity of Hope Medical Center2025-04-152025-05-26
Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
Atezolizumab, Biospecimen Collection, Cemiplimab - Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
Phase 2RecruitingEmory University202025-04-092026-02-12
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
Biospecimen Collection, Cemiplimab, Computed Tomography - Eyelid Squamous Cell Carcinoma, Recurrent Eyelid Squamous Cell Carcinoma
Phase 3SuspendedNational Cancer Institute (NCI)4202025-02-182026-11-03
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
Biopsy, Biospecimen Collection, Bone Marrow Biopsy - Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma
Phase 1RecruitingMayo Clinic212024-01-052026-07-01
Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery
Cemiplimab, Computed Tomography, Biospecimen Collection - Locally Advanced Basal Cell Carcinoma, Basal Cell Carcinoma
Phase 2SuspendedThomas Jefferson University702023-07-052026-06-10
Cemiplimab/Peg-Interferon-α in Advanced CSCC
Cemiplimab-Rwlc, PEG-IFN alfa-2a - Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma
Phase 1WithdrawnBaptist Health South Florida2023-07-012023-08-09
Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)
Cemiplimab-Rwlc - Head and Neck Squamous Cell Carcinoma, HNSCC
Phase 2WithdrawnUniversity of Miami2022-07-012022-08-04

Showing 20 of 31. Sign in to see all of them.

Conditions studied

Carcinoma, Non-Small-Cell Lung (7)  ·  Lung Neoplasms (5)  ·  Laryngeal Neoplasms (3)  ·  Mouth Neoplasms (3)  ·  Skin Neoplasms (3)  ·  Squamous Cell Carcinoma of Head and Neck (3)  ·  Carcinoma (2)  ·  Glioblastoma (2)  ·  Lymphoma, Large-Cell, Anaplastic (2)  ·  Lymphoma, T-Cell (2)  ·  Mycosis Fungoides (2)  ·  Oropharyngeal Neoplasms (2)  ·  Adrenocortical Carcinoma (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)

Sponsors

National Cancer Institute (NCI) (7)  ·  Mayo Clinic (3)  ·  City of Hope Medical Center (2)  ·  Emory University (2)  ·  H. Lee Moffitt Cancer Center and Research Institute (2)  ·  M.D. Anderson Cancer Center (2)  ·  University of Southern California (2)  ·  Alaunos Therapeutics (1)  ·  Baptist Health South Florida (1)  ·  Columbia University (1)  ·  Georgetown University (1)  ·  Marcelo Bonomi (1)  ·  Northwestern University (1)  ·  Roswell Park Cancer Institute (1)  ·  SWOG Cancer Research Network (1)

Countries

United States (28)  ·  Australia (1)  ·  Canada (1)

Top investigators

Gino K In, MD (2)  ·  Ahmad Tarhini, MD, PhD (1)  ·  Arya Amini (1)  ·  Bhavana Konda (1)  ·  Christine H Chung, MD (1)  ·  Chukwuemeka Ikpeazu, MD (1)  ·  Guilherme Rabinowits, M.D. (1)  ·  Jaymes Holland (1)  ·  Jennifer W Carlisle (1)  ·  Jochen H Lorch, MD (1)  ·  Jonathan Kessler (1)  ·  Joselle Cook, M.B.B.S. (1)  ·  Joseph Curry, MD (1)  ·  Joshua Reuss, MD (1)  ·  Kah Whye Peng, PhD (1)

Results publications

PMID 35175355, PMID 34187851, PMID 34850166, PMID 36898933, PMID 41137728

NIH funding

P30CA014089 (2), P30CA033572 (2), P30CA138292 (2), P50CA186781 (2), R01CA262613 (2), U10CA180868 (2), UM1CA186691 (2), P30CA012197 (1), P30CA060553 (1), U10CA180821 (1), U10CA180888 (1), UM1CA186690 (1), UM1CA186712 (1)